Table 2.

Technologies available for identifying and quantifying BCR-ABL KD mutations


Technology

Sensitivity, %

Specificity

Bias*

Availability

Reference
Direct sequencing   15-25   ++   No   +++   19,21,22,24,59  
Subcloning and sequencing   9   +++   No   ++   20  
Denaturing high-performance liquid chromatography (D-HPLC)   0.1-10   ++   No   ++   66-68  
Pyrosequencing   5   ++   No   +   55,69  
Double-gradient denaturing electrophoresis   5   ++   No   +   57  
Fluorescence PCR and PNA clamping   0.2   ++   Yes   +   58  
Allele-specific oligonucleotide PCR (ASO-PCR)
 
0.01
 
++
 
Yes
 
+
 
53,59,60
 

Technology

Sensitivity, %

Specificity

Bias*

Availability

Reference
Direct sequencing   15-25   ++   No   +++   19,21,22,24,59  
Subcloning and sequencing   9   +++   No   ++   20  
Denaturing high-performance liquid chromatography (D-HPLC)   0.1-10   ++   No   ++   66-68  
Pyrosequencing   5   ++   No   +   55,69  
Double-gradient denaturing electrophoresis   5   ++   No   +   57  
Fluorescence PCR and PNA clamping   0.2   ++   Yes   +   58  
Allele-specific oligonucleotide PCR (ASO-PCR)
 
0.01
 
++
 
Yes
 
+
 
53,59,60
 

PNA indicates peptide nucleic acid.

*

Bias indicates that the test is designed to detect specific mutations.

Close Modal

or Create an Account

Close Modal
Close Modal